Purple Biotech Ltd Financials

PPBT

Source SEC Filings (10-K/10-Q) Updated Dec 31, 2021 Currency USD FYE December

This page shows Purple Biotech Ltd (PPBT) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 3 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Export CSV

Key Financial Metrics

Revenue

N/A

EBITDA

N/A

Free Cash Flow

N/A

Net Income

$17.8M

YoY-37.9%

Purple Biotech Ltd reported $17.8M in net income in fiscal year 2021. This represents a decrease of 37.9% from the prior year.

EPS (Diluted)

N/A

Cash & Debt

N/A

Dividends Per Share

N/A

Shares Outstanding

178M

Purple Biotech Ltd had 178M shares outstanding in fiscal year 2021. This represents an increase of 934.3% from the prior year.

Gross Margin

N/A

Operating Margin

N/A

Net Margin

N/A

Return on Equity

N/A

R&D Spending

N/A

Share Buybacks

N/A

Capital Expenditures

N/A

PPBT Income Statement

Metric	FY21	FY20	FY19
Revenue	N/A	N/A	N/A
Cost of Revenue	N/A	N/A	N/A
Gross Profit	N/A	N/A	N/A
R&D Expenses	N/A	N/A	N/A
SG&A Expenses	$6.1M+1.8%	$6.0M+36.6%	$4.4M
Operating Income	N/A	N/A	N/A
Interest Expense	N/A	N/A	N/A
Income Tax	N/A	N/A	N/A
Net Income	$17.8M-37.9%	$28.7M+430.7%	$5.4M
EPS (Diluted)	N/A	N/A	N/A